Pro Medicus Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMCUF research report →
Companywww.promed.com.au
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus. net, an e-health platform.
- CEO
- Sam Aaron Hupert
- IPO
- 2021
- Employees
- 75
- HQ
- Richmond, VIC, AU
Price Chart
Valuation
- Market Cap
- $9.31B
- P/E
- 57.53
- P/S
- 56.12
- P/B
- 34.72
- EV/EBITDA
- 71.02
- Div Yield
- 0.48%
Profitability
- Gross Margin
- 78.41%
- Op Margin
- 74.17%
- Net Margin
- 97.56%
- ROE
- 72.67%
- ROIC
- 25.88%
Growth & Income
- Revenue
- $212.91M · 31.83%
- Net Income
- $115.22M · 39.16%
- EPS
- $1.10 · 39.24%
- Op Income
- $157.61M
- FCF YoY
- 38.08%
Performance & Tape
- 52W High
- $218.25
- 52W Low
- $74.52
- 50D MA
- $92.48
- 200D MA
- $142.34
- Beta
- 0.59
- Avg Volume
- 391
Get TickerSpark's AI analysis on PMCUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PMCUF Coverage
We haven't published any research on PMCUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PMCUF Report →